Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001763494-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Jan 31, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
517,487
Total Value
$3,230,315.62
P&L
+inf% (+$11,570,328.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 31, 2026 | Grant/Award | 113,800 | $0.00 | $0.00 | 532,973 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 3, 2026 | Sale | 66,452 | $32.06 | $2,130,451.12 | 466,521 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 3, 2026 | Sale | 33,635 | $32.70 | $1,099,864.50 | 432,886 | Direct | โ | View Details | |
Director | Employee stock option (right to buy) | Derivative | Jan 31, 2026 | Grant/Award | 303,600 | $0.00 | $0.00 | 303,600 | Direct | โ | View Details |